innovative health clinic semaglutide and tirzepatide are both injectable medications used in medical weight management—but they act on different metabolic pathways, which is why patient selection matters. Semaglutide (GLP-1 receptor agonist): • Primarily targets appetite The Frontier of Metabolic Health:

Quick Answer: Allodynia is not listed as an adverse effect in FDA-approved prescribing information for semaglutide products

The good news is that food choices can help a lot

By suppressing glucagon after meals, GLP-1 removes another driver of high blood sugar

Womens Health Fat storage to the midsection

The Women's Health Initiative, a large randomized controlled trial, reported increased risks of breast cancer, cardiovascular disease, stroke, and thromboembolic events in women taking combined estrogen and progestin therapy [11]

Here are seven essential insights for Brooklyn residents on the effects of weight loss drug withdrawal